The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,294,197 in first-year total cost, median $364,000.
Most frequent study sections
- HIV Immunopathogenesis and Vaccine Development Study Section[HIVD]3
Most frequent institutions
- EMORY UNIVERSITY1
- UNIVERSITY OF MIAMI SCHOOL OF MEDICINE1
- UNIVERSITY OF NEBRASKA MEDICAL CENTER1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Immunomodulatory drug interventions for the prevention of host immune responses toward AAV-delivered anti-HIV antibodies1R21OD037752-01A1 | FUCHS, SEBASTIAN PATRICK | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL | $630,197 | HIVD |
| 2024 | Artificial thymic organoid platform to study T cell development and HIV/SIV infection using SIV/macaque model of HIV/AIDS1R21OD035572-01A1 | RAHMAN, SHEIKH ABDUL | EMORY UNIVERSITY, GA | $364,000 | HIVD |
| 2024 | SIV reservoirs dynamics during aging1R21OD037751-01 | ACHARYA, ARPAN | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | $300,000 | HIVD |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.